
Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir
Keywords: Hepatitis C virus; Drug resistance; NS5A; NS5B; DAA; Ledipasvir; Sofosbuvir; Ribavirin;